James Alderson
Internal Medicine · Birmingham, ALNPI 1609808823
Payments from drug & device makers
Across 462 payments — averaging $13.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$942
- Pfizer$909
- AbbVie$849
- Boehringer Ingelheim$414
- Bayer$251
- Amgen$232
- plus $3K from 35 others
What the payments were for
- Food & beverage$6,206100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,206 in reported general payments places this provider in the 85th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $13,048 |
| Atorvastatin Calcium | 73 | $1,463 |
| Pravastatin Sodium | 50 | $1,150 |
| Losartan Potassium | 29 | $405 |
| Levothyroxine Sodium | 26 | $326 |
| Amlodipine Besylate | 46 | $238 |
| Pantoprazole Sodium | 19 | $230 |
| Omeprazole | 16 | $209 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 21 | $201 |
| Alendronate Sodium | 25 | $196 |
| Simvastatin | 17 | $186 |
| Gabapentin | 26 | $182 |
| Lisinopril | 25 | $182 |
| Montelukast Sodium | 12 | $178 |
| Metformin Hcl | 16 | $162 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $909 | $13,04817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Birmingham
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
- Ramy TomaBirmingham$5.1M
- William KirbyBirmingham$2.3M
- Jordan VaughnBirmingham$1.6M
- Stefanie KrickBirmingham$527K
- Ryan WeldonBirmingham$458K
- Ashraf KhanBirmingham$215K
- Robert LewisBirmingham$201K
- David WynneBirmingham$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.